Literature DB >> 33095037

Multimorbidity Among Adult Outpatients With Type 1 Diabetes in Germany.

Louisa van den Boom1, Gebhard Buchal1, Marcel Kaiser2, Karel Kostev3.   

Abstract

AIM: The aim of this cross-sectional retrospective study was to estimate the prevalence of different physical and psychiatric disorders as well as multimorbidity in outpatients with type 1 diabetes (T1D) in Germany.
METHODS: A total of 6967 adult patients with T1D from 958 general or diabetologist practices in Germany between January 2015 and December 2019 from the Disease Analyzer database (IQVIA) were included. The main outcome of the study was the prevalence of different diabetes-related and nondiabetes-related disorders within 12 months prior to the last outpatient visit. Multivariate logistic regression models were fitted with multimorbidity differently defined as >2, >3, >4, and >5 different disorders as a dependent variable and age, sex, glycated hemoglobin (HbA1c) values, and insulin pump therapy as impact variables.
RESULTS: Mean age (standard deviation [SD]) was 45.3 (16.7) years; 42.9% were women, the mean HbA1c was 7.9% (SD: 1.4%). The most frequent disorder was arterial hypertension (31.2%), followed by dyslipidemia (26.4%), dorsalgia (20.4%), diabetic neuropathy (17.3%), and depression (14.6%). The proportion of thyroid gland disorders, retinopathy, urethritis, iron deficiency anemia, and psychiatric disorders was higher in women than in men. Hypertension and mental and behavioral disorders due to the use of tobacco were higher in men. On average, each patient was diagnosed with 3.1 different disorders. Age had the strongest association with multimorbidity, followed by HbA1c value and female sex.
CONCLUSION: In summary, patients with T1D are often multimorbid, and the multimorbidity is associated with higher gender, female sex, and high HbA1c values. Understanding all of these factors can help practitioners create a risk profile for every patient.

Entities:  

Keywords:  HbA1c; multimorbidity; sex differences; type 1 diabetes

Mesh:

Substances:

Year:  2020        PMID: 33095037      PMCID: PMC8875064          DOI: 10.1177/1932296820965261

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  28 in total

1.  Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus.

Authors:  Kristy Iglay; Hakima Hannachi; Patrick Joseph Howie; Jinfei Xu; Xueying Li; Samuel S Engel; Lori M Moore; Swapnil Rajpathak
Journal:  Curr Med Res Opin       Date:  2016-04-04       Impact factor: 2.580

Review 2.  Type 1 diabetes.

Authors:  Linda A DiMeglio; Carmella Evans-Molina; Richard A Oram
Journal:  Lancet       Date:  2018-06-16       Impact factor: 79.321

3.  Prevalence of psychiatric disorders in patients with diabetes types 1 and 2.

Authors:  Ana Claudia C de Ornelas Maia; Arthur de Azevedo Braga; Amanda Brouwers; Antonio Egidio Nardi; Adriana Cardoso de Oliveira e Silva
Journal:  Compr Psychiatry       Date:  2012-04-21       Impact factor: 3.735

4.  Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV).

Authors:  K Otfried Schwab; Jürgen Doerfer; Wolfgang Hecker; Jürgen Grulich-Henn; Dagobert Wiemann; Olga Kordonouri; Peter Beyer; Reinhard W Holl
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

5.  Basic characteristics and representativeness of the German Disease Analyzer database
.

Authors:  Wolfgang Rathmann; Brenda Bongaerts; Hans-Joachim Carius; Silvia Kruppert; Karel Kostev
Journal:  Int J Clin Pharmacol Ther       Date:  2018-10       Impact factor: 1.366

6.  The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.

Authors:  David M Nathan
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

7.  Association of insulin-manipulation and psychiatric disorders: A systematic epidemiological evaluation of adolescents with type 1 diabetes in Austria.

Authors:  Gabriele Berger; Thomas Waldhoer; Irene Barrientos; Daniela Kunkel; Birgit M Rami-Merhar; Edith Schober; Andreas Karwautz; Gudrun Wagner
Journal:  Pediatr Diabetes       Date:  2018-10-26       Impact factor: 4.866

8.  Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases.

Authors:  Gesine van Mark; Stefanie Lanzinger; Ralf Barion; Michael Degenhardt; Simone Badis; Horst Noll; Thomas Danne; Peter Bramlage; Jochen Seufert; Reinhard W Holl
Journal:  Ther Adv Endocrinol Metab       Date:  2019-02-28       Impact factor: 3.565

Review 9.  MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus.

Authors:  F S Hough; D D Pierroz; C Cooper; S L Ferrari
Journal:  Eur J Endocrinol       Date:  2015-11-04       Impact factor: 6.664

10.  Recurrent vertebral fractures in a young adult: a closer look at bone health in type 1 diabetes mellitus.

Authors:  Eleanor P Thong; Sarah Catford; Julie Fletcher; Phillip Wong; Peter J Fuller; Helena Teede; Frances Milat
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.